Acta Med. 2000, 43: 3-8
https://doi.org/10.14712/18059694.2019.109
Paroxysmal Nocturnal Hemoglobinuria (Membrane Defect, Pathogenesis, Aplastic Anemia, Diagnosis)
References
1. Proc Natl Acad Sci U.S.A. 1999; 96:5209-14.
< DJ, Nafa K, Pakde Suwan K et al. Clonal populations of hematopoietic cells with paroxysmal hemoglobinuria genotype and phenotype are present in normal individuals. https://doi.org/10.1073/pnas.96.9.5209>
<PubMed>
2. J Biol Chem 1991; 267:25347-51.
C, Schubert J, Veda et al. Affected paroxysmal nocturnal haemoglobinuria T lymphocytes harbour a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A thy-1-murine lymphoma mutants.
3. Br J Haematol 1999; 105:366-8.
< M, Guardiola P, Garderet L. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1111/j.1365-2141.1999.01374.x>
4. Eur J Haematol 1991; 47:179-82.
< M, Fehr J. fc(III receptors) (FcR III) on granulocytes: a new specific and sensitivity test for paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1111/j.1600-0609.1991.tb01552.x>
5. Lancet 1994; 343:951-3.
< M, Mason GJ, Hillmen P et al. Somatic mutations and cellular selection in paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1016/S0140-6736(94)90068-X>
6. Br J Haematol 1986; 64:737-43.
< HS, Hancke S, Rosenklint A et al. Ultrasonic demonstration of clinical and subclinical hepatic venous thrombosis in paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1111/j.1365-2141.1986.tb02235.x>
7. Proc Natl Acad Sci U.S.A. 1997; 94:8756-60.
< RA, Vala MS, Barber JP et al. Resistance to apoptosis caused by PIGA gene mutation in paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1073/pnas.94.16.8756>
<PubMed>
8. Blood 1953; 8:769-812.
WH. Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to underlying pathogenic mechanisms.
9. Arch Dis Child 1944; 19:155-62.
< JV, Gilpin A. Refractory anaemia (Fanconi type). https://doi.org/10.1136/adc.19.100.155>
<PubMed>
10. Lancet 1938; 1:479-91.
< JV, Israels MCG, Wilkinson JF. Paroxysmal nocturnal hemoglobinuria of the Marchiafave type. https://doi.org/10.1016/S0140-6736(00)89566-5>
11. Br J. Haematol 1961; 7:442-57.
< JV, Lewis SM. Paroxysmal nocturnal hemoglobinuria: variation in clinical severity and association with bone-marrow hypoplasia. https://doi.org/10.1111/j.1365-2141.1961.tb00354.x>
12. Lancet 1949; 1:390-2.
< JV, Mollison PL. Survival of transfused erythrocytes from a donor with nocturnal haemoglobinuria. https://doi.org/10.1016/S0140-6736(49)90704-7>
13. Acta Med Patav 1956; 16:310-35.
G, Gihotto G, Mastella G. L’aceticolinesterase eritrocitaria. II. Rapporti con le malatie emolitiche.
14. Am J Hematol 1987; 16:75-7.
MA, Di Lorenzo PE, Mohler DN. Intestinal infarction caused by paroxysmal nocturnal hemoglobinuria.
15. Blood 1997; 90(suppl 1):407a.
DE, Nagakura S, Tanawattana-Charoen P et al. The PNH phenotype (GPIanchored protein-deficiency) protects hematopoietic target against lymphotoxic attack (Abstract).
16. Ann Intern Med 1999; 131:401-408.
< DE, Tanawattana-Charoen P, Boccuni P et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. https://doi.org/10.7326/0003-4819-131-6-199909210-00002>
17. Klin Wschr 1928; 7:2045-7.
< J. Eine neue Form intermitierender Hämoglobinurie (hemoglobinuria paroxysmalis nocturna). https://doi.org/10.1007/BF01846778>
18. Blood 1996; 87:5332-40.
SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
19. New Engl J Med 1937; 217:915-7.
< TH. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. Study of the mechanism of hemolysis in relation to acid-base equilibrium. https://doi.org/10.1056/NEJM193712022172307>
20. J Clin Invest 1939; 18:657-73.
< TH, Dingle JH. Studies on destruction of red cells. II. chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: certain immunological aspects of the hemolytic mechanism with special reference to serum complement. https://doi.org/10.1172/JCI101081>
<PubMed>
21. Blood 1970; 35:462-75.
RC, Jenkins DE, Arnold AB. Diagnostic specificity of the sucrose hemolysis test for paroxysmal nocturnal hemoglobinuria.
22. Leukemia Lymph. 1999; 32:401-26.
< JW, Koscick R, Lazarus HM et al. Leukemia arising out of paroxysmal nocturnal hemoglobinuria. https://doi.org/10.3109/10428199909058399>
23. Proc Natl Acad Sci U.S.A. 1993; 90:5272-76.
< P, Bessler M, Mason PJ et al. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1073/pnas.90.11.5272>
<PubMed>
24. N Engl J Med 1995; 333:1253-58.
< P, Lewis PM, Bessler M et al. Natural history of paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1056/NEJM199511093331904>
25. J Clin Invest 1989; 84:7-17.
< MH, Frederick LR, Bernshaw NY et al. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1172/JCI114172>
<PubMed>
26. Blood 1997; 90:2716-22.
K, Nakakuma H, Kawaguchi T. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.
27. Chrobák L, Brabec V. Paroxysmální noční hemoglobinurie. Thomayerova sbírka, SZN Praha 1965. 102 pp.
28. Folia haemat (Lpz) 1964; 82:256-293.
L, Brabec V, Wiedermann B. et al. Paroxysmale nächliche Hämoglobinurie. Bericht über 8 Fälle unter besonderer Berücksichtigung von Panzytopenie und Knochenmarkaplasie.
29. Sborník věd. prací VLA J. Ev. P. 1957; 5:135-155.
L, Groh J. Paroxysmální noční hemoglobinurie.
30. Chrobák L, Toušková M, Žák P et al. Paroxysmální noční hemoglobinurie (patogeneze a vztah k dřeňové aplazii). Hematol. Transfusiol. 2000; v tisku.
31. Am J. Hematol 1992; 39:283-8.
< K, Witherspoon RP, Storb R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1002/ajh.2830390409>
32. Blood 1990; 76:1181-7.
HJ, Schmidt RE. The PIG-anchoring defect in NK lymphocytes of PNH patients.
33. Br J Haematol 1981; 48:1-6.
< AI, Hertmann RC. Annotation: The Budd-Chiari syndrome and paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1111/j.1365-2141.1981.00001.x>
34. Blood 1952; 7:842-49.
H. Possible paroxysmal nocturnal hemoglobinuria with pronounced pancytopenia, reticulocytopenia, and without hemoglobinuria simulating aplastic anemia.
35. Br J Haematol 1965; 11:549-56.
< SM, Dacie JV. Neutrophil (leukocyte) alkaline phosphatase in paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1111/j.1365-2141.1965.tb00099.x>
36. Br J Haematol 1960; 6:122-39.
< SM, Szur L, Dacie JV. The pattern of erythrocyte destruction in haemolytic anaemia as studied with radioactive chromium. https://doi.org/10.1111/j.1365-2141.1960.tb06224.x>
37. Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Haematology 1996; Panache Design Singapore, p. 120-7.
38. Current Opinion Hematol 1996; 3:101-3.
< L, Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1097/00062752-199603020-00001>
39. Cell 1997; 80:1-4.
< L, Bessler M, Rotoli B. Somatic mutation in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? https://doi.org/10.1016/S0092-8674(00)81850-4>
40. Policlinico, Sez Med 1928; 35:105-17.
E. Anemia emolitica con emosiderinuria perpetua.
41. Quart J Med 1949; 18:105-21.
J. The Marchiafava-Micheli syndrome (Paroxysmal nocturnal haemoglobinuria).
42. J Intern Med 1994; 235:85-9.
< MF, Hillmen P, Jackson J et al. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1111/j.1365-2796.1994.tb01037.x>
43. Immunulogy 1990; 7:1-9.
S, Morgan BP, Davies A et al. Human protectin (CD 59), an 18.000-20.000 MW complement lysis restricting factor, inhibits C 5b-8 catalysed insertion of C9 into lipid bilayers.
44. Science 1993; 259:1318-20.
< T, Takeda J, Iida Y et al. The cloning of PIG-A, a component in the early step of GPI-achor biosynthesis. https://doi.org/10.1126/science.7680492>
45. Blood 1999; 94:2963-70.
Y, Kinoshita T, Maeda Y. et al. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria.
46. Leukemia Lymph 1993; 92:137-42.
< JI, Takahashi M, Fuse I et al. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia. https://doi.org/10.3109/10428199309059582>
47. Blood Cells Mol Dis 1998; 24:370-84.
< K, Bessler M, Castro-Malaspina H et al. The spectrum of somatic mutation in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. https://doi.org/10.1006/bcmd.1998.0203>
48. Blood 1995; 86:4650-5.
K, Mason PJ, Hillman P et al. Mutations in the PIG-A gene causing Paroxysmal Nocturnal Hemoglobinuria are mainly of the frameshift type.
49. Blood 1994; 84:309-14.
H, Nagakura S, Horikawa K et al. Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.
50. Blood 1995; 85:1371-6.
H, Nagakura S, Iwamoto N et al. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia.
51. Proc Natl Acad Sci U.S.A. 1983; 80:5430-3.
< A, March JP, Rosenfeld SJ et al. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. https://doi.org/10.1073/pnas.80.16.5066>
<PubMed>
52. Blood 1970; 36:145-52.
SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells.
53. Blood 1992; 79:1447-55.
M, Plesner T, Roune E et al. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria.
54. Br J Haematol 1999; 107:148-53.
< AC, Rollinson SJ, Richards S. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment. https://doi.org/10.1046/j.1365-2141.1999.01676.x>
55. Blood 1990; 75:1595-1601.
WF. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria.
56. J Clin Invest 1966; 45:736-48.
< WJ, Dacie JV. Immune lysis of normal human and paroxysmal nocturnal haemoglobinuria (PNH) red blood cells: I. The sensitivity of PNH red cells to lysis by complement and specific antibody. https://doi.org/10.1172/JCI105388>
<PubMed>
57. Blood 1995; 86:3277-86.
WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria.
58. Blood Reviews 1993; 7:75.
< B, Bessler M, Afinito F, del Vecchio L. Membrane proteins in paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1016/S0268-960X(05)80017-7>
59. Semin. Hematol 1989; 26:201.
B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria.
60. Blood 1984; 64:847-51.
B, Robledo R, Scarpato N et al. Two populations of erythroid cell progenitors in paroxysmal nocturnal haemoglobinuria.
61. Br J Haematol 1999; 104:392-6.
< R, Marsh J, Čevreska L et al. Bone marrow transplants for paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1046/j.1365-2141.1999.01195.x>
62. Blood 1993; 81:1855-62.
T, Terasawa T, Hashimoto C et al. Discordant and hetorogenous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
63. Br J Haematol 1993; 85:378-86.
< T, Terasawa T, Saitoh Y et al. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour cytometry with monoclonal antibodies to DAF and CD 59/MACIF. https://doi.org/10.1111/j.1365-2141.1993.tb03182.x>
64. Blood 1990; 76:1181-7.
J, Uchiechowski P, Delany P et al. The PIG-anchoring defect in NK lymphocytes of PNH patients.
65. Br J Haematol 1995; 89:72-8.
< AA, Nagarajan S, Weinberg JB et al. PIG-A, DAF and protooncogene expression in paroxysmal nocturnal haemoglobinuria - associated acute myelogenous leukaemia blasts. https://doi.org/10.1111/j.1365-2141.1995.tb08908.x>
66. Dtsch Med Wschr 1882; 8:1-3.
< P. Paroxysmale Hämoglobinurie. https://doi.org/10.1055/s-0029-1196307>
67. Cell 1993; 73:703-11.
< J, Miyata T, Kawagoe K et al. Deficiency of the PIG-A gene in paroxysmal nocturnal haemoglobinuria. https://doi.org/10.1016/0092-8674(93)90250-T>
68. Blood 1999; 94:2945-54.
G, Dominguez C, Rosti V et al. Increased sensitivity to complement and decreased red blood cell life span in mice mosaic for a non-functional Piga gene.
69. Br J Haematol 1988; 69:413-18.
< A, Gratwohl A, Nissen C et al. Late haematological complications in severe aplastic anaemia. https://doi.org/10.1111/j.1365-2141.1988.tb02382.x>
70. Folia haemat (Lpz) 1955; 73:284-300.
M. Paroxysmale Nachthämoglobinurie.
71. Fragilité globulaire. Rev Méd 1911; 31:63-9.
HAA. Ictère hémolytigue avec crises hémoglobinurigues.
72. Blood 1990; 76:1853-9.
CE, Huizinga TW, Van’t Veer-Korthof ET et al. Deficiency of glycosyl-phosphatidyl-inositol-linked membrane proteins of leukocytes in paroxysmal nocturnal hemoglobinuria. Description of a new diagnostic cytofluorometric assay.
73. Voswinckel P. Der schwarze Urine Berlin, Germany Blackwell, 1993. Panache Design Singapore, p. 120-7.
74. Blood 1993; 82:1192-6.
T, Hall SE, Ortel TL et al. Complement induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.
75. N Engl J Med 1990; 323:1184-1189.
< M, Ueda E, Kinoshita T et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD 59) as a cause of paroxysmal nocturnal hemoglobinuria. https://doi.org/10.1056/NEJM199010253231707>
76. Blood 1995; 85:3367-77.
NS, Barret AJ. The treatment of acquired aplastic anemia.